Search research articles
Contact Us
Filters
Showing results (21-30 of 75) with videos related to
Page
of 8
Sort By:
Cancer Epidemiology
|
September 15, 2015
Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy
Laura Finn, Lisa Sproat, Michael G Heckman, et al.
International Journal of Clinical Oncology
|
October 12, 2012
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma
Daruka Mahadevan, Donald W Northfelt, Pavani Chalasani, et al.
British Journal of Cancer
|
June 6, 2018
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study
Raoul Tibes, Mitesh J Borad, Corina E Dutcus, et al.
Blood
|
October 9, 2008
Functional proteomic profiling of AML predicts response and survival
Steven M Kornblau, Raoul Tibes, Yi Hua Qiu, et al.
Molecular Cancer
|
August 20, 2010
RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma
Shilpi Arora, Irma M Gonzales, R Tanner Hagelstrom, et al.
Cancer Medicine
|
January 24, 2013
18-FDG PET/CT assessment of basal cell carcinoma with vismodegib
Curtis A Thacker, Glen J Weiss, Raoul Tibes, et al.
Computational and Structural Biotechnology Journal
|
May 22, 2020
Corrigendum to "Triazolo[4,5-<i>d</i>]pyrimidines as validated general control nonderepressible 2 (GCN2) protein kinase inhibitors reduce growth of leukemia cells" [Comput. Struct. Biotechnol. J. 16 (2018) 350-360]
Lea Lough, Dan Sherman, Manuel Becerra-Flores, et al.
American Journal of Hematology
|
January 10, 2023
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression
Aref Al-Kali, Raoul Tibes, Pamela Atherton, et al.
Cancer
|
May 12, 2006
Activity of alemtuzumab in patients with CD52-positive acute leukemia
Raoul Tibes, Michael J Keating, Alessandra Ferrajoli, et al.
Cancer
|
April 12, 2023
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms
Raoul Tibes, Heidi E Kosiorek, Amylou C Dueck, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 75) with videos related to
Sort By:
Page
of 8
Cancer Epidemiology
|
September 15, 2015
Epidemiology of adult acute myeloid leukemia: Impact of exposures on clinical phenotypes and outcomes after therapy
Laura Finn, Lisa Sproat, Michael G Heckman, et al.
International Journal of Clinical Oncology
|
October 12, 2012
Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma
Daruka Mahadevan, Donald W Northfelt, Pavani Chalasani, et al.
British Journal of Cancer
|
June 6, 2018
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study
Raoul Tibes, Mitesh J Borad, Corina E Dutcus, et al.
Blood
|
October 9, 2008
Functional proteomic profiling of AML predicts response and survival
Steven M Kornblau, Raoul Tibes, Yi Hua Qiu, et al.
Molecular Cancer
|
August 20, 2010
RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma
Shilpi Arora, Irma M Gonzales, R Tanner Hagelstrom, et al.
Cancer Medicine
|
January 24, 2013
18-FDG PET/CT assessment of basal cell carcinoma with vismodegib
Curtis A Thacker, Glen J Weiss, Raoul Tibes, et al.
Computational and Structural Biotechnology Journal
|
May 22, 2020
Corrigendum to "Triazolo[4,5-<i>d</i>]pyrimidines as validated general control nonderepressible 2 (GCN2) protein kinase inhibitors reduce growth of leukemia cells" [Comput. Struct. Biotechnol. J. 16 (2018) 350-360]
Lea Lough, Dan Sherman, Manuel Becerra-Flores, et al.
American Journal of Hematology
|
January 10, 2023
A phase II study of combination daunorubicin, cytarabine (Ara-c), and nilotinib (TAsigna) (DATA) in patients newly diagnosed with acute myeloid leukemia with KIT expression
Aref Al-Kali, Raoul Tibes, Pamela Atherton, et al.
Cancer
|
May 12, 2006
Activity of alemtuzumab in patients with CD52-positive acute leukemia
Raoul Tibes, Michael J Keating, Alessandra Ferrajoli, et al.
Cancer
|
April 12, 2023
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms
Raoul Tibes, Heidi E Kosiorek, Amylou C Dueck, et al.
Page
of 8